CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 144 filers reported holding CARDLYTICS INC in Q1 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $264 | +151.4% | 15,977 | -48.2% | 0.00% | +200.0% |
Q1 2023 | $105 | -41.0% | 30,821 | +0.3% | 0.00% | -50.0% |
Q4 2022 | $178 | -99.9% | 30,716 | +55.9% | 0.00% | 0.0% |
Q3 2022 | $185,000 | -88.0% | 19,700 | -71.4% | 0.00% | -87.5% |
Q2 2022 | $1,536,000 | +49.9% | 68,839 | +269.2% | 0.02% | +100.0% |
Q1 2022 | $1,025,000 | +7.7% | 18,647 | +29.5% | 0.01% | +60.0% |
Q4 2021 | $952,000 | -3.8% | 14,398 | +22.1% | 0.01% | 0.0% |
Q3 2021 | $990,000 | +465.7% | 11,796 | +757.9% | 0.01% | +400.0% |
Q2 2021 | $175,000 | -67.8% | 1,375 | -72.3% | 0.00% | -66.7% |
Q1 2021 | $544,000 | +113.3% | 4,961 | +178.1% | 0.00% | +200.0% |
Q4 2020 | $255,000 | +44.9% | 1,784 | -29.1% | 0.00% | 0.0% |
Q2 2020 | $176,000 | +60.0% | 2,515 | +43.2% | 0.00% | 0.0% |
Q4 2019 | $110,000 | -89.2% | 1,756 | -97.1% | 0.00% | -88.9% |
Q1 2019 | $1,014,000 | +56.5% | 61,277 | +2.3% | 0.01% | +50.0% |
Q4 2018 | $648,000 | -56.8% | 59,875 | -0.1% | 0.01% | -45.5% |
Q3 2018 | $1,501,000 | – | 59,950 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
Cannell Capital | 626,975 | $16,289,000 | 4.62% |
Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |